Business Analyst - Analytics Capabilities at Eli Lilly and Company

Toronto, Ontario, Canada

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Bachelor’s or Master’s degree in Business, Information Systems, Data Analytics, or a related field
Experience with datasets from the Healthcare, Pharma, or Health Insurance industries
Strong understanding of key performance indicators (KPIs) and metric calculations relevant to the pharma and biotech sector
3–6 years of experience in business analysis, analytics strategy, or data product management
Strong understanding of analytics platforms, data visualization tools, and data architecture
Experience working with cross-functional teams including data engineers, BI developers, and business stakeholders
Experience with Canadian data sets (IQVIA, EMRs, Claims, …)
Excellent communication, facilitation, and stakeholder management skills
Proficiency in SQL and familiarity with data modeling concepts

Responsibilities

Partner with business units to assess current analytics maturity and identify capability gaps
Define and prioritize analytics use cases aligned with strategic goals
Support the development and rollout of analytics frameworks, governance models, and best practices
Collaborate with stakeholders to gather and document business requirements for analytics solutions, dashboards, and data products
Translate business needs into functional specifications for technical data integrator, data engineering, front end developers and BI teams
Facilitate workshops to align on KPIs, metrics definitions, and reporting standards
Drive adoption of analytics platforms (e.g., Power BI, Tableau, …) across business units
Provide training, onboarding, and support to users to improve data literacy and self-service capabilities
Evaluate and recommend new tools and technologies to enhance analytics capabilities
Work with data governance teams to ensure consistent definitions, data lineage, and metadata management
Monitor data quality issues and coordinate resolution with technical teams
Promote responsible data usage and compliance with privacy regulations
Define success metrics for analytics initiatives and track performance over time
Conduct post-implementation reviews to assess impact and identify areas for improvement
Stay current with industry trends and emerging technologies in analytics and business intelligence

Skills

Business Analysis

Data Analysis

Requirements Gathering

Stakeholder Management

Analytics

Data Literacy

Data Products

Analytics Frameworks

Governance Models

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free